Skip to main content
NIH funding notice RFA-AT-20-004

HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional)

Closed on June 29, 2020.

Posted
January 23, 2020
Close date
June 29, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,603,884 in first-year total cost, median $801,942.

Most frequent study sections

  1. Special Emphasis Panel[ZAT1 SM (18)]2

Most frequent institutions

  1. UNIVERSITY OF ILLINOIS AT CHICAGO1
  2. UNIVERSITY OF UTAH1
Competing awards under RFA-AT-20-004 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain1UG3AT011265-01DOORENBOS, ARDITH ZEZENWA, MIRIAM OMELEBELEMOLOKIE, ROBERT ESCHLAEGER, JUDITH MICHELLESHAH, NIRMISH RUNIVERSITY OF ILLINOIS AT CHICAGO, IL$827,226ZAT1
2020Nonpharmacologic Pain Management in FQHC primary care clinics1UG3NR019943-01FRITZ, JULIE MUNIVERSITY OF UTAH, UT$776,658ZAT1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.